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Tuberculosis  (TB)  remains  one  of  the  main 
threats to mankind. Despite the efforts of the 
scientific community toward understanding this 
disease, 9 million active TB cases and 2 mil-
lion deaths occur every year (Dye et al., 1999; 
Dye, 2006). Although immune cell activation is 
required to limit the growth of Mycobacterium   
tuberculosis (Mtb), if uncontrolled it can damage 
host tissue. The balance between protection and 
pathological  consequences  is  the  crux  of  TB 
pathogenesis. It is therefore crucial to under-
stand and discriminate the components of the 
immune response that are protective from those 
that are damaging to effectively intervene in TB. 
Indeed, the hope for improved vaccination re-
lies on the possibility that these responses can be 
independently manipulated.
The discrimination between protective and 
pathological  components  of  the  immune  re-
sponse during TB is particularly important be-
cause M. bovis bacille Calmette-Guérin (BCG), 
currently the only available vaccine against TB, 
has variable efficacy (ranging from 0 to 80%; 
Colditz et al., 1994) and its protection may last 
for only 10 yr (Sterne et al., 1998; Weir et al., 
2008). As a result of this apparent loss of activity, 
revaccination  with  BCG,  DNA  vaccines,  or 
subunit vaccines is considered as a potential con-
trol strategy; however, the safety of this strategy 
in a highly exposed population is not yet fully 
defined. The issue of safety arises because of the 
fact that repeated exposure of Mtb-infected   
animals  to  mycobacterial  antigens  can  initiate 
immune-mediated  pathology.  Specifically,  the 
exposure of Mtb-infected guinea pigs to either 
live mycobacteria or mycobacterial antigens 
results in necrotic inflammation at the site of 
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Infection usually leads to the development of acquired immune responses associated with 
clearance or control of the infecting organism. However, if not adequately regulated, 
immune-mediated pathology can result. Tuberculosis is a worldwide threat, and develop-
ment of an effective vaccine requires that the protective immune response to Mycobacte-
rium tuberculosis (Mtb) be dissected from the pathological immune response. This 
distinction is particularly important if new vaccines are to be delivered to Mtb-exposed 
individuals, as repeated antigenic exposure can lead to pathological complications. Using a 
model wherein mice are vaccinated with bacille Calmette-Guérin after Mtb infection, we 
show that repeated vaccination results in increased IL-17, tumor necrosis factor, IL-6, and 
MIP-2 expression, influx of granulocytes/neutrophils, and lung tissue damage. This patho-
logical response is abrogated in mice deficient in the gene encoding IL-23p19 or in the 
presence of IL-17–blocking antibody. This finding that repeated exposure to mycobacterial 
antigen promotes enhanced IL-17–dependent pathological consequences has important 
implications for the design of effective vaccines against Mtb.
© 2010 Cruz et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e1610 IL-17 in postexposure BCG vaccination | Cruz et al.
with the granulocyte/neutrophil infiltrate. These results sup-
port a pathogenic role of IL-17–producing antigen-specific 
cells during TB. Thus, the development of Th17 responses 
after vaccination and their impact on chronic infection should 
be considered.
RESULTS AND DISCUSSION
Repeated exposure to BCG after Mtb infection results  
in a significant increase in pathological inflammation  
in the lungs of Mtb-infected mice
To dissect protective from pathological responses to Mtb we 
chose to use a previously described model of accelerated host 
damage wherein Mtb-infected mice receive repeated BCG 
vaccination (Turner et al., 2000). C57BL/6 (B6) mice were 
infected with Mtb and repeatedly injected subcutaneously 
with either saline or BCG. Control mice that were not Mtb-
infected underwent the repeated BCG vaccination protocol 
alone. Macroscopic examination of the lungs at 90 d after 
Mtb  infection  demonstrated  that  repeated  BCG  exposure   
resulted in a larger number of detectable lesions (Fig. 1 a; 
Turner et al., 2000). Consistent with this observation, micro-
scopic analysis of the lesions indicated that although Mtb- 
infected mice had small yet defined lesions, mice repeatedly 
vaccinated  with  BCG  exhibited  lesions  of  increased  size   
(Fig. 1 b). Mice that were not Mtb infected but were vacci-
nated with BCG three times did not show any signs of   
inflammation or pathological consequences in the lungs 
(unpublished data). When the histological sections were 
scored in a blinded manner according to an inflammatory   
index, there was a clear and reproducible increase in inflam-
mation between the mice receiving three postinfection vac-
cinations and those receiving either no vaccination or just 
one vaccination (Fig. 1 c). As previously described, this dif-
ference in inflammation was not associated with differences 
in bacterial burden in the lungs or spleens over the interval 
tested (Table S1; Turner et al., 2000), suggesting that al-
though lung lesions were increased in size, the hosts’ ability 
to contain the bacterial burden was not affected.
To determine whether increased pathology was associ-
ated with altered expression of effector molecules within the 
lung, we compared the relative mRNA expression between 
the  unvaccinated  and  vaccinated  groups.  The  repeatedly 
vaccinated  infected  mice  exhibited  an  increase  in  MIP-2 
(Fig. 1 d), a chemokine associated with granulocyte influx, 
as well as TNF (Fig. 1 e) and IL-6 (Fig. 1 f), both active in-
flammatory mediators.
Repeated exposure to BCG after Mtb infection results  
in a significant increase in the number of antigen-specific 
IL-17–producing cells
To determine whether the pathological inflammation resulted 
from a change in the nature of the immune response, we next 
quantified the expression of T cell effector cytokines within the 
lungs of infected and vaccinated mice. We found that although 
expression of the protective cytokine IFN- mRNA was not 
significantly altered (Fig. 2 a), for the potentially damaging   
challenge, a response that has been termed the Koch phenom-
enon (Koch, 1891). Although the cellular and molecular de-
terminants of this response are undefined, it appears that the 
severity of the Koch phenomenon depends on the dose of an-
tigen, as lower doses of antigen are used to induce a delayed-
type hypersensitivity response; this is the basis for the current 
skin test for detecting latently infected individuals (Rich, 1944). 
A damaging focal response at the site of initial infection can 
also be triggered by repeated vaccine (BCG or DNA) chal-
lenge of Mtb-infected animals. This leads to the development 
of severe pathology, including necrosis and increased granulo-
cyte influx in preexisting lesions in the lung (Turner et al., 
2000; Moreira et al., 2002; Taylor et al., 2003). The perceived 
risk of increased pathological consequences as a result of vacci-
nation in previously exposed humans has lead to initial safety 
screens being performed on novel vaccine candidates (Sander 
et al., 2009). However, results from these types of studies 
should be interpreted cautiously, as the extent of repeated   
antigen exposure will differ greatly depending on the level   
of disease in the community. Therefore, there is a concern   
that adult postexposure vaccination to prevent the reactiva-
tion of TB could lead to pathology, particularly in highly 
exposed populations.
The importance of the cytokine IFN- in the protective 
response to Mtb is well established (North and Young, 2004); 
however, the mediator of pathological responses has not been 
identified. The Koch-like pathologies described in the previ-
ous paragraph were consistently associated with neutrophil in-
flux and could therefore be mediated by IL-17 (Miyamoto   
et al., 2003; Kolls and Linden, 2004). Further, although IL-17 
is induced during mycobacterial infection, it does not play a 
significant role during the early period of infection (up to 100 d;   
Khader and Cooper, 2008). In addition, IFN- is able to regu-
late the IL-17 response during BCG infection (Cruz et al., 
2006), and in the absence of IFN- signaling in the stroma, an 
increase in neutrophil involvement in the TB granuloma is 
seen (DesVignes and Ernst, 2009); these data reflect an impor-
tant regulatory activity for IFN- in the control of pathology 
in TB. Therefore, we hypothesized that repeated antigen ex-
posure would allow the IL-17 response to overcome the IFN-–
mediated regulation and thereby mediate immunopathological 
consequences,  and  that  the  Koch  phenomenon  may  result 
from an unregulated IL-17 response.
To test our hypothesis and investigate the mechanisms 
underlying the pathogenic response to repeated antigen ex-
posure, we examined the pathological cellular response in an 
established mouse model of repeated antigen exposure that 
leads to increased pathology (Turner et al., 2000; Moreira   
et al., 2002; Taylor et al., 2003). Specifically, Mtb-infected 
mice were repeatedly vaccinated subcutaneously with BCG 
to promote an immunopathologic response. We found that 
enhanced pathology was associated with a dramatic increase 
in the number of antigen-specific IL-17–producing cells in 
the lungs of infected and revaccinated animals. Importantly, 
in the absence of IL-23 or in the presence of anti–IL-17 anti-
body, the enhanced pathological response was ablated, along JEM VOL. 207, August 2, 2010  1611
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nonvaccinated or singly vaccinated mice (Fig. 2 c). In contrast, 
the number of IFN-–producing antigen-specific cells did not 
change under the conditions tested (Fig. 2 c).
To determine whether the strong IL-17 response at day 90 
in the mice vaccinated three times was simply a result of sam-
pling time relative to the most recent BCG vaccination, we 
analyzed the antigen-specific IFN- and IL-17 responses at 45 
and 60 d after both a second (Fig. 2 d) and a third (Fig. 2 e) 
vaccination. We found that in both cases there was an increase 
in the number of antigen-specific IL-17–producing cells at 
cytokine IL-17 it was significantly increased in the mice vacci-
nated three times after infection compared with those mice re-
ceiving only one or no vaccination (Fig. 2 b). To determine if 
this IL-17 response was associated with the acquired antigen-
specific response to infection, we measured the number of 
antigen-specific cells making the protective cytokine IFN- and 
the potentially damaging cytokine IL-17 using a peptide-driven 
ELISPOT.  Strikingly,  repeated  vaccination  of  Mtb-infected 
mice with BCG induced a significant increase in the number   
of  antigen-specific  IL-17–producing  cells  as  compared  with 
Figure 1.  Repeated exposure of Mtb-
infected mice to BCG leads to increased 
pathology. B6 mice were infected with Mtb 
and vaccinated with BCG either one 
(Mtb+1BCG) or three times (Mtb+3BCG).  
(a) Macroscopic image of the lungs of Mtb-
infected mice either left unvaccinated (left) or 
repeatedly vaccinated (right) after infection 
with BCG. (b) Microscopic images of lung 
lesions of Mtb-infected mice either left un-
vaccinated (left) or vaccinated one (middle) or 
three times (right) with BCG after infection. 
Bars, 50 µm. (c) The degree of inflammation 
in the lungs of multiple mice was quantified 
in a blinded manner using a scale (0, no in-
flammation; 1, mild inflammation; 2, abun-
dant inflammation; 3, exacerbated 
inflammation). The values from 11 lungs from three independent experiments were combined to give a mean (±SD). (d–f) Lung total RNA was extracted 
90 d after Mtb infection from mice either left unvaccinated (black bars) or vaccinated one (white bars) or three times (gray bars) after infection with 
BCG, and the expression of mRNA encoding MIP-2 (d), IL-6 (e), and TNF (f) was assessed by real-time PCR and normalized to the expression of HPRT.  
In d–f, data points represent mean values (n = 3–4 mice per group) with one representative experiment out of two total shown. *, P < 0.05; **, P < 0.01; 
and ***, P < 0.001, determined as described in Materials and methods.
Figure 2.  Repeated exposure to BCG 
after Mtb infection results in a significant 
increase in the number of antigen-specific 
IL-17–producing cells. B6 mice were  
infected with Mtb and vaccinated with BCG 
either one (Mtb+1BCG), two (Mtb+2BCG), or 
three times (Mtb+3BCG). (a and b) Lung total 
RNA was extracted 90 d after Mtb infection 
from mice either unvaccinated (black bars) or 
vaccinated one (white bars) or three times 
(gray bars) after infection with BCG, and the 
expression of mRNA encoding IFN- (a) and 
IL-17 (b) was assessed by real-time PCR  
and normalized to the expression of HPRT.  
(c) Lung cells were recovered 90 d after Mtb 
infection from mice either left unvaccinated 
(black bars) or vaccinated one (white bars) or 
three times (gray bars) after infection with 
BCG and stimulated with irradiated spleno-
cytes pulsed with Ag85 peptide, and IL-17– and IFN-–producing cells were measured by ELISPOT. (d and e) Lung cells were recovered from mice in-
fected with Mtb and either left unvaccinated (black bars) or vaccinated two (white bars) or three times (gray bars) after infection with BCG. The number 
of antigen-specific IL-17– or IFN-–producing cells in the lungs was determined by ELISPOT either 45 or 60 d after final vaccination. (f) Lung total RNA 
was extracted from Mtb-infected mice either left unvaccinated (black bars) or vaccinated two (white bars) or three times (gray bars) after infection with 
BCG 45 or 60 d after final vaccination. The expression of mRNA encoding IL-23a was assessed by real-time PCR and normalized to the expression of 
HPRT. For all panels, data points represent mean values (n = 3–4 mice per group) with one representative experiment out of two total shown. *, P < 0.05; 
**, P < 0.01; and ***, P < 0.001, determined as described in Materials and methods.1612 IL-17 in postexposure BCG vaccination | Cruz et al.
MIP-2 in the B6 mice (Fig. 1 e), we reasoned that neutrophils 
may be involved in the pathology induced by BCG reexpo-
sure. To investigate this, we assessed the number of GR1+ 
cells (likely neutrophils) by immunohistochemistry present in 
the lung lesions. There is a modest level of neutrophil accu-
mulation in the nonvaccinated infected B6 mice (Fig. 3,   
b and c, green cells), but as we have shown previously this was 
not dependent on IL-23 (Khader et al., 2005). Importantly, 
we found that the number of GR1+ cells within the granulo-
mata of BCG-vaccinated Mtb-infected B6 mice was increased 
when mice were repeatedly vaccinated (Fig. 3, b and c).   
In contrast to the unvaccinated mice, however, it was clear that 
this increase in GR1+ cell accumulation and pathology was 
dependent on the presence of IL-23 (Fig. 3, b and c). In fact, 
in the absence of IL-23, the number of GR1+ cells actually 
dropped after vaccination (Fig. 3 b). As we have previously 
shown that IL-17 responses are regulated by IFN- in BCG 
infections (Cruz et al., 2006), we wanted to determine the 
potential for the relative levels of IFN-– and IL-17–producing 
cells to be linked to the accumulation of GR1+ cells and   
pathology; to do this, we calculated the ratios of IFN-–   
to  IL-17–producing  antigen-specific  cells  in  the  lungs  by 
ELISPOT. We found that IL-17–producing cells specific for 
Ag85 were increased upon vaccination (not depicted for this 
experiment but similar to that depicted in Fig. 2 c), and that 
the ratio of IFN-– to IL-17–producing cells was significantly 
different between B6 and B6.il23a/ mice but not signifi-
cantly different between vaccinated and unvaccinated mice 
day 45 after vaccination; however, the increased IL-17 re-
sponse was only sustained to day 60 after vaccination, when 
animals were challenged three times with BCG (Fig. 2 e). 
Consistent with the sustained antigen-specific IL-17 response, 
we observed an increased expression of il23a in the lungs of 
the infected mice receiving three BCG vaccinations (Fig. 2 f). 
We hypothesize that the repeated antigenic challenge results 
in conditions in the lung that are permissive for the persistence 
of IL-17–producing cells.
Granulocyte accumulation within the granuloma depends  
on IL-23
We  previously  demonstrated  that  the  absence  of  IL-23   
modulates the IL-17 and inflammatory response to primary 
Mtb infection in the lung (Khader et al., 2005). This, together 
with data showing the role of IL-23 and IL-17 in neutrophil 
accumulation and function (Stark et al., 2005; Zelante et al., 
2007), prompted us to examine the role of IL-23 in the en-
hanced pathological response to repeated BCG exposure in   
the Mtb-infected lung using mice lacking the IL-23a subunit 
(B6.il23a/). Although Mtb-infected B6 mice repeatedly ex-
posed to BCG showed a significantly increased granuloma size 
compared with the unexposed B6 mice, the repeated BCG 
exposure did not significantly increase the granuloma size in 
B6.il23a/  mice  relative  to  the  unvaccinated  B6.il23a/ 
mice (Fig. 3 a).
Because IL-17 and IL-23 have been implicated in neutro-
phil recruitment and function and we detected an increase in 
Figure 3.  IL-23 is required for the increased immunopathologic response after repeated BCG exposure in Mtb-infected mice. B6 and 
B6.il23a/ mice were infected with Mtb and either left unvaccinated (Mtb; black bars) or vaccinated two (Mtb+2BCG; white bars) or three times 
(Mtb+3BCG; gray bars) after infection with BCG. (a) Morphometric analysis of the size of inflammatory lesions in the lungs of treated mice. (b) Number of 
GR1+ cells within lung lesions of B6 or B6.il23a/ Mtb-infected mice. (c) Immunohistology of GR1+ cells (green signal indicates GR1 stain, red signal indi-
cates activated macrophages, and blue signal indicates cell nuclei) in B6 or il23a/ Mtb-infected mice either left unvaccinated (top) or vaccinated three 
times (middle, B6; bottom, il23a/) after infection with BCG. Bars, 200 µm. (d) Cells from the lungs of treated mice were restimulated in vitro with Ag85 
peptide, IFN-– or IL-17–producing cells were measured by ELISPOT, and the ratio of IFN-– to IL-17–producing cells was calculated. (e and f) Cells were 
isolated from the DLNs of B6 or B6.il23a/ mice at the site of vaccination after two (white bars) or three (gray bars) vaccinations, and the number of  
IFN-– (e) or IL-17–producing cells (f) was determined by ELISPOT. In a and b and d–f, data points represent mean values (n = 4 mice per group). *, P < 0.05; 
**, P < 0.01; and ***, P < 0.001, determined as described in Materials and methods. For all panels, one representative experiment out of two total is shown.JEM VOL. 207, August 2, 2010  1613
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Mtb-infection (2 d before the third BCG vaccination) until 
day 90. Importantly, neutralization of IL-17 reduced the in-
flammation induced by revaccination (Fig. 4 a), as well as the 
granuloma size (Fig. 4 b) and the number of GR1+ cells in   
the granuloma (Fig. 4 c) and within the lung (Fig. 4 d). The anti– 
IL-17 treatment also significantly reduced the level of the   
neutrophil-recruiting cytokine MIP-2 in the lungs of the triple-
vaccinated mice (Fig. 4 e). Therefore, it appears that the increase 
in granuloma size and neutrophil influx resulting from repeated 
antigen exposure are dependent both on IL-23 and IL-17.
In this report we reveal the immune mechanisms leading to 
pathology caused by reexposure of Mtb-infected animals to 
BCG vaccination. We show that enhanced pathological con-
sequences are associated with an IL-17–dominated response, 
with increased production of inflammatory cytokines, recruit-
ment  of  granulocytes/neutrophils,  and  increased  tissue   
involvement. This enhanced pathology and inflammatory 
infiltrate is completely dependent on the cytokines IL-23 and 
IL-17. This is a critical and novel observation, as the mediators 
of the pathogenic cellular response in TB have not been previ-
ously described. This observation is also critical for rational 
vaccine development and delivery of immune-mediated inter-
vention vaccines to control this disease. Indeed, this study has 
important implications that should be considered in the design 
of new vaccines or vaccination protocols.
Based on our results, one possible suggestion would be to 
limit the induction of memory T cells capable of generating   
an IL-17 response, as this would limit immunopathogenesis. 
However, we have previously demonstrated that IL-17 pro-
duction is required during the recall response to Mtb challenge 
in the mouse model for an accelerated expression of protection 
(Fig. 3 d). In a preliminary assessment of the impact of re-
peated vaccination and the presence of IL-23 on the induc-
tion of T cells, we compared the number of cells producing 
IFN- (Fig. 3 e) or IL-17 (Fig. 3 f) in the draining LNs (DLNs) 
of the vaccine sites. We found that there was not a significant 
difference in the number of cytokine-producing cells between 
mice vaccinated two or three times, and much as we have 
seen previously (Khader et al., 2007), the absence of IL-23 
does  not  significantly  impact  early  induction  of  IL-17  re-
sponses (Fig. 3 f). Collectively, our data show that vaccine- 
induced increased immunopathology is associated with IL-17 
(Fig. 2, b and c) and dependent on il23a (Fig. 3). We also 
show that an exacerbated recruitment of GR1+ cells (likely 
neutrophils) is associated with the pathology caused by BCG 
reexposure of Mtb-infected mice (Fig. 3, b and c). Further, 
although an increased presence of IL-17–producing T cells is 
associated with increased pathology, it does not appear to be 
associated with an altered ratio of IFN-– to IL-17–producing 
cells (Fig. 3 d). Finally, the observation that expression of il23a 
is increased in the lungs of mice vaccinated three times (Fig. 2 f) 
suggests that availability of IL-23 in the lung may be responsi-
ble for the persistent IL-17 response in these mice.
Neutralization of IL-17 improves the pathology associated 
with BCG revaccination
Because IL-23 is associated with the development and main-
tenance of IL-17 responses in Mtb infection (Khader et al., 
2005), we tested whether the response to BCG vaccination 
was dependent on the excessive IL-17 production in the triple-
vaccinated Mtb-infected mice. To do this, we treated these 
mice with anti–IL-17 antibody starting on day 43 after 
Figure 4.  IL-17 is required for the increased immunopathologic response after repeated BCG exposure in Mtb-infected mice. B6 mice  
were infected with Mtb and then either left unvaccinated (Mtb) or vaccinated with BCG three times and either treated with isotype control antibody 
(Mtb+3BCG+Iso) or anti–IL-17 antibody (Mtb+3BCG+antiIL17). (a) Histological images of lung lesions in Mtb-infected mice either left unvaccinated (left) 
or vaccinated with BCG three times and either treated with isotype control antibody (middle) or anti–IL-17 antibody (right). Bars, 50 µm. (b–d) Morpho-
metric quantification of lesion size (b), number of GR1+ cells within lung lesions (c), and number of GR1+ cells in total lung measured by flow cytometry 
(d) in Mtb-infected mice either left unvaccinated (black bars) or vaccinated with BCG three times and either treated with isotype control antibody (gray 
bars) or anti–IL-17 antibody (white bars). (e) Total mRNA was extracted from the lungs of mice treated as in panel a, and the expression of MIP-2 mRNA 
was assessed by real-time PCR normalized to HPRT. In b–e, data points represent mean values (n = 4 animals per group), and for all panels one represen-
tative experiment out of two total is shown. *, P < 0.05; **, P < 0.01; and ***, P < 0.001, determined as described in Materials and methods.1614 IL-17 in postexposure BCG vaccination | Cruz et al.
recruiting neutrophils, the current data may reflect differences 
in the nature of neutrophil activation in the presence and ab-
sence of IL-17 and IL-23. Specifically, neutrophils can be pro-
tective during fungal infection, but when exposed to excess 
IL-23 or IL-17, their function is altered and they become more 
able to mediate tissue damage (Zelante et al., 2007).
The role of neutrophils in TB is currently an area of in-
tense investigation. Careful analysis reveals that neutrophils 
are a dominant site for bacterial presence in the sputum and 
bronchoalveolar lavage of patients with active TB, suggesting 
a role for these cells as permissive hosts (Eum et al., 2010).   
In addition, rapid accumulation of neutrophils that are permis-
sive for bacterial growth is a dominant feature in genetically 
susceptible mice (Eruslanov et al., 2005; Keller et al., 2006). 
Further, recent work has shown that restriction of neutrophil 
accumulation is dependent on the IFN- receptor–dependent 
activity  of  indoleamine-2,3-dioxygenase  by  radio-resistant 
cells within the lung, which results in increased tryptophan 
catabolic products that likely act to inhibit IL-17–producing 
cells in situ (DesVignes and Ernst, 2009). Further, blockade of 
IL-17 in Mtb-infected mice can limit neutrophil recruitment 
(Redford et al., 2010). Collectively, these data support a 
largely negative role for neutrophils in TB pathogenesis, and 
our data expand these observations by demonstrating that in-
creased pathology is directly dependent on IL-23– and IL-17–
mediated neutrophil recruitment.
To generate a host response by vaccination that eliminates 
the infection, we must continue to define both the protective 
and pathogenic immune responses to Mtb infection. Other-
wise, vaccination may promote detrimental consequences, as 
we show in this report. In particular, in locations where the 
disease is highly prevalent, the delivery of a new vaccine to an 
individual who has been BCG vaccinated and/or has subclini-
cal Mtb infection may result in unexpected tissue damage. The 
more we know of the natural and vaccine-induced response to 
Mtb infection, the better placed we will be to improve immu-
nointervention. In addition, it should be determined whether 
a high frequency of antigen-specific IL-17–producing cells in 
patients is indicative of increased lesion size or disruption of 
granuloma structure.
MATERIALS AND METHODS
Bacteria. The H37Rv strain of Mtb and M. bovis BCG Pasteur were grown 
in Proskauer-Beck medium containing 0.05% Tween 80 to mid–log phase 
and frozen at –70°C.
Animals and experimental infection and antibody treatment. 8-wk-old 
female C57BL/6 (B6) mice were obtained from Charles River or the Jackson 
Laboratory. IL-23p19–deficient mice (B6.il23a/) were bred at the Trudeau 
Institute from stock provided by N. Ghilardi and F.J. deSauvage (Genentech, 
South  San  Francisco,  CA).  Mice  were  either  anesthetized  with  ketamine/ 
medetomidine and infected intranasally with 4 × 104 CFU Mtb H37Rv, resulting 
in a lung dose of 102 CFU (Figs. 1, 2, and 4), or were infected via the aerosol 
route (final dose of 102 CFU) as previously described (Fig. 3; Roberts et al., 
2002). Mice were divided into four groups. The first group was only infected with 
Mtb. The second group was vaccinated subcutaneously with 106 BCG 15 d after 
Mtb infection. The third group received a BCG inoculation at days 15 and 30 
after Mtb infection. The fourth group received three doses of BCG at days 15, 
30, and 45 after Mtb infection. Control groups received saline instead of Mtb 
(Khader et al., 2007). Although on the surface this may appear 
contradictory, it merely demonstrates that there is a time and a 
place for each cytokine such that whereas early expression of 
IL-17 is important for rapid accumulation of protective mem-
ory cells, we now show that its expression in excess and during 
an ongoing infection is clearly detrimental. It is therefore of ex-
treme importance to understand the function of specific com-
ponents of the immune response not only as a function of time 
but also of location, as this is crucial to understanding their 
function in vivo.
Importantly, the detrimental role of IL-17 during chronic 
infection is not associated with control of the bacterial burden 
but in the level of inflammatory involvement of the intersti-
tium. This is not surprising, as the number of antigen-specific 
IFN-–producing cells is not diminished and it would appear 
that the enhanced IL-17 response does not inhibit the protec-
tive response. Similarly, it appears that although IFN- can 
regulate the IL-17 during mycobacterial infection (Cruz et al., 
2006), repeated vaccination overcomes the ability of IFN-  
to do this. How then is repeated vaccination changing the   
immunopathologic response? We see both higher IL-17 mRNA 
and a higher frequency and number of antigen-specific IL-17–
producing cells in the lungs of repeatedly vaccinated mice. The 
generation of IL-17–producing T cells as opposed to antigen-
specific cells of other functional phenotypes depends on the 
cytokines available during initial activation of naive T cells 
(McGeachy and Cua, 2008). The functional impact of these in-
duced T cells also then depends on the expression of stimulatory 
and inhibitory cytokines at the site of infection/inflammation. 
Our data suggest that it is not altered induction of Th1   
and Th17 cells in the DLNs but rather increased presence of 
IL-23 at the site of inflammation that supports the persistence 
of Th17 cells after three vaccinations. It is possible that in-
creased apoptosis at the site of inflammation results in condi-
tions suitable for induction of IL-17–producing cells (Torchinsky   
et al., 2009), and that the triple vaccination induces cells   
capable of inducing this apoptosis. That the absence of il23a 
results in the loss of the immunopathologic consequences   
of repeated vaccination suggests that, as for the nonpatho-
genic IL-17 response to mycobacterial infection, the enhanced   
IL-17 response caused by repeated exposure depends on IL-23 
(Khader et al., 2005).
Our data correlating the presence of IL-17 and MIP-2 dur-
ing the enhanced pathological response suggest that, as in the 
LPS-induced  lung  inflammation  model  (Miyamoto  et  al., 
2003), IL-17 drives MIP-2 that recruits neutrophils to the tis-
sue. The association between IL-17 and the frequency of neu-
trophils within the lung lesions of the repeatedly vaccinated 
mice suggests that granulocyte accumulation is a consequence 
of enhanced IL-17 activity in the Mtb-infected lung. Interest-
ingly the absence of IL-17 during pulmonary mycobacterial 
infection only modestly alters the early inflammatory response 
(Khader et al., 2005; Umemura et al., 2007). This suggests that 
IL-17 plays a minor role early in the response, and that the 
pathogenic role occurs as the balance between IFN- and   
IL-17 is altered in favor of IL-17. In addition to a direct role in JEM VOL. 207, August 2, 2010  1615
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